GLP-1 Diabetes Drug Neutral for the Heart (CME/CE)

(MedPage Today) -- Once-weekly exenatide safe for CV outcomes but falls short of showing benefit

Source: MedPage Today Endocrinology - September 14, 2017 Category: Endocrinology Source Type: news